Your browser doesn't support javascript.
loading
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
Birch, David G; Bernstein, Paul S; Iannacone, Alessandro; Pennesi, Mark E; Lam, Byron L; Heckenlively, John; Csaky, Karl; Hartnett, Mary Elizabeth; Winthrop, Kevin L; Jayasundera, Thiran; Hughbanks-Wheaton, Dianna K; Warner, Judith; Yang, Paul; Fish, Gary Edd; Teske, Michael P; Sklaver, Neal L; Erker, Laura; Chegarnov, Elvira; Smith, Travis; Wahle, Aimee; VanVeldhuisen, Paul C; McCormack, Jennifer; Lindblad, Robert; Bramer, Steven; Rose, Stephen; Zilliox, Patricia; Francis, Peter J; Weleber, Richard G.
Afiliação
  • Birch DG; Retina Foundation of the Southwest, Dallas, Texas.
  • Bernstein PS; University of Utah School of Medicine, Salt Lake City.
  • Iannacone A; University of Tennessee Health Sciences Center, Hamilton Eye Institute, Memphis.
  • Pennesi ME; now with Duke University School of Medicine, Duke Eye Center, Durham, North Carolina.
  • Lam BL; Oregon Health & Science University, Casey Eye Institute, Portland.
  • Heckenlively J; University of Miami, Bascom Palmer Eye Institute, Miami, Florida.
  • Csaky K; University of Michigan, Kellogg Eye Center, Ann Arbor.
  • Hartnett ME; Retina Foundation of the Southwest, Dallas, Texas.
  • Winthrop KL; University of Utah School of Medicine, Salt Lake City.
  • Jayasundera T; now with Duke University School of Medicine, Duke Eye Center, Durham, North Carolina.
  • Hughbanks-Wheaton DK; University of Michigan, Kellogg Eye Center, Ann Arbor.
  • Warner J; Retina Foundation of the Southwest, Dallas, Texas.
  • Yang P; University of Utah School of Medicine, Salt Lake City.
  • Fish GE; Oregon Health & Science University, Casey Eye Institute, Portland.
  • Teske MP; Retina Foundation of the Southwest, Dallas, Texas.
  • Sklaver NL; University of Utah School of Medicine, Salt Lake City.
  • Erker L; Retina Foundation of the Southwest, Dallas, Texas.
  • Chegarnov E; Oregon Health & Science University, Casey Reading Center, Portland.
  • Smith T; Oregon Health & Science University, Casey Reading Center, Portland.
  • Wahle A; Oregon Health & Science University, Casey Reading Center, Portland.
  • VanVeldhuisen PC; The Emmes Corporation, Rockville, Maryland.
  • McCormack J; The Emmes Corporation, Rockville, Maryland.
  • Lindblad R; The Emmes Corporation, Rockville, Maryland.
  • Bramer S; The Emmes Corporation, Rockville, Maryland.
  • Rose S; Foundation Fighting Blindness, Columbia, Maryland.
  • Zilliox P; Foundation Fighting Blindness, Columbia, Maryland.
  • Francis PJ; Foundation Fighting Blindness, Columbia, Maryland.
  • Weleber RG; Foundation Fighting Blindness, Columbia, Maryland.
JAMA Ophthalmol ; 136(8): 849-856, 2018 08 01.
Article em En | MEDLINE | ID: mdl-29879277
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Visão / Retinose Pigmentar / Ácido Valproico / Anticonvulsivantes Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos da Visão / Retinose Pigmentar / Ácido Valproico / Anticonvulsivantes Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos